| Identification | Back Directory | [Name]
Cinoctramide | [CAS]
28598-08-5 | [Synonyms]
Cinoctramide
Octahydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]azocine
2-Propen-1-one, 1-(hexahydro-1(2H)-azocinyl)-3-(3,4,5-trimethoxyphenyl)- | [Molecular Formula]
C19H27NO4 | [MDL Number]
MFCD00869007 | [MOL File]
28598-08-5.mol | [Molecular Weight]
333.42 |
| Chemical Properties | Back Directory | [Boiling point ]
517.6±50.0 °C(Predicted) | [density ]
1.092±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 125 mg/mL (374.90 mM) | [form ]
Solid | [pka]
-0.78±0.20(Predicted) | [color ]
Light yellow to yellow |
| Hazard Information | Back Directory | [Uses]
Cinoctramide is an intermediate of pharmaceutical synthesis. Cinoctramide can be used for the research of autoimmune diseases[1]. | [References]
[1] Joshua David Mezrich, et al. Method of Treating Transplant Rejection and Autoimmune Diseases. Patent US20180042899A1. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
Musechem
|
| Tel: |
+1-800-259-7612 |
| Website: |
www.musechem.com |
| Company Name: |
MedChemExpress
|
| Tel: |
021-58955995 |
| Website: |
www.medchemexpress.com |
|